Platelet response in aspirin adherent pregnant women

We conducted an unbiased genome-wide assessment of genomic factors that may influence response to low-dose aspirin in pregnant women at high risk of pre-eclampsia in two pregnancy cohorts: Liverpool (n=91) and Dublin (n=91). We applied UK Axiom microarray technology for GWAS investigations. We specified tight phenotyping with COX-selective urinary 11-dehydrothromboxane B2 (pg/mg creatinine) and accounted for adherence/platelet exposure to aspirin by detection of aspirin’s principal urinary metabolite, SUA, with nuclear magnetic resonance (NMR).

Type: Other
Archiver: EGA European Genome-Phenome Archive

2 Datasets

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00010002093	Dublin Aspirin platelet response genomics cohort	UK Biobank Axiom array	91
EGAD00010002094	Liverpool Aspirin platelet response genomics cohort	UK Biobank Axiom array	91